Barely Significant
← all excerpts

Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis.

Front Immunol · 2025 · PMC12602472 · PMID 41229435

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
In contrast, the network meta-analysis showed a trend toward PFS benefit for amiva-lazer-chemo but did not reach statistical significance, potentially due to limited sample sizes in both analyses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.